Trending Topic

< 1 min

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

This corrects the article: “Ioannou A. Evolution of Disease-modifying Therapy for Transthyretin Cardiac Amyloidosis. Heart International. 2024;18(1):30-37”. Two typography errors were included incorrectly due to an editorial error. In Table 1, “eplontersen” was incorrectly written as “eplomtersen”. This has been corrected in the text. In the section “Eplontersen”, the administration schedule should be written as […]

Dynamic T-wave Changes with Hump Appearance from a Higher Intercostal Space in a Short QT Syndrome

Serhat Koca, Ozcan Ozeke, Serkan Cay, Firat Ozcan, Fazil Arisoy, Omer Alyan, Serkan Topaloglu, Dursun Aras
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jun 7th 2017 European Journal of Arrhythmia & Electrophysiology, 2017;3(1):21–2 DOI: https://doi.org/10.17925/EJAE.2017.03.01.21
Select a Section…
1

Abstract

Overview

Short QT syndrome (SQTS) is an inherited channelopathy associated with marked shortened QT intervals and sudden cardiac death. It is imperative for physicians to recognise the clinical features of the SQTS in making a timely correct diagnosis; however, the diagnosis of SQTS is further complicated by the presence of an overlapping range of QT intervals between affected cases and apparently healthy subjects. We present a case of SQTS with dynamic T-wave changes and T-wave hump appearance in the higher intercostal recordings, and speculate that these dynamic changes are a surrogate marker of underlying repolarisation abnormality and may help in the diagnosis of SQTS.

Keywords

Short QT syndrome, T-wave hump, electrocardiogram, intercostal space

2

Article

Short QT syndrome (SQTS) is a cardiac channelopathy characterised by an abnormally short QT interval and an increased risk of atrial and ventricular fibrillation.1 As it often involves young patients with an apparently normal heart, it is imperative for physicians to recognise the clinical features of the SQTS in making a timely correct diagnosis. The diagnosis of SQTS is further complicated by the presence of an overlapping range of QT intervals between affected cases and apparently healthy subjects.2 The dynamic wave abnormalities may be an important clue for this distinction.

Case report
A 28-year-old man was admitted after aborted sudden cardiac death with an electrical storm with four successive episodes of ventricular fibrillation. corrected QT (QTc) was 312 msec, suggesting SQTS (see Figure 1). His family history showed that an elder brother died suddenly at age 22, and his two brothers both were asymptomatic with short QT on their electrocardiograms (ECGs). The ECG taken from a higher intercostal space revealed dynamic T-wave changes in the precordial leads (see Figure 2, arrows) with a ‘T-wave hump’ appearance in V2 (see Figure 2B, arrow). Transthoracic echocardiography showed no structural abnormalities. An implantable cardiac defibrillator was implanted, and the patient was discharged with oral quinidine therapy without any complications, including T-wave oversensing.

Discussion
Electrocardiography is the primary important step in the diagnosis of SQTS but ECG findings may be easily ignored. Timely diagnosis and optimal treatment can significantly improve the overall prognosis of the patient and family members with SQTS.3 The main diagnostic criterion is a short QT interval seen in the baseline ECG, with QTc intervals ≤330 ms or QTc <360 msec with one or more of the following: a pathogenic mutation, family history of SQTS, family history of sudden death at age ≤40 and/or survival of a ventricular tachycardia/ventricular fibrillation (VT/VF) episode in the absence of heart disease.3On the other hand, using the QT interval corrected by Bazett’s formula in the proposed diagnostic criteria has important limitations.4 As already observed in the first reported patient diagnosed.with SQTS, the QT interval in SQTS changes very little with changes in heart rate, and correction of the QT interval is therefore barely necessary at normal heart rates.5

In addition to the QT interval, other distinctive features associated with the ECGs of SQTS patients have been reported, including the relative absence of an ST-segment. The data suggest that extreme abbreviation of the Jpoint-T peak interval may help distinguish patients with a SQTS from healthy subjects with an apparent abbreviation of the ST-segment and shortened QT intervals.6 Moreover, the Tpeak-Tend interval and the Tpeak-Tend/QT ratio, an ECG index of spatial dispersion of repolarisation, are significantly augmented in cases of SQTS.7 Measurement of T-wave alternans in SQTS, even if disappointing, does not imply that dynamic changes in QT interval or increased QT apex-QT end interval are useless.8 In the current case, we detected the dynamic T-wave changes

with a ‘T-wave hump’ appearance in the higher intercostal ECG recordings, and speculate that those changes may reflect underlying repolarisation abnormality. Indeed, the T-wave changes (‘humps’ or notches) that have been well described in long QT syndrome (LQTS) patients9,10 are a marker of increased arrhythmogenic risk and are not only restricted to patients with LQTS, but are also described in patients without LQTS.11

Therefore, these spatial changes by higher intercostal space recordings as a surrogate marker of underlying repolarisation abnormality may help in the diagnosis of SQTS in addition to the measurement of the duration of QT interval from the 12-lead ECG,12 and may be used as a clue for differentiation of SQTS patients from normal healthy individuals with a short QT interval. However, further research is necessary to prove if T-wave hump is indeed another clue for identifying SQTS patients.

2

References

1. Mazzanti A, Kanthan A, Monteforte N, et al., Novel insight into the natural history of short QT syndrome, J Am Coll Cardiol, 2014;63:1300–8.

2. Gollob MH, Redpath CJ, Roberts JD, The short QT syndrome: proposed diagnostic criteria, J Am Coll Cardiol, 2011;57:802–12.

3. Priori SG, Wilde AA, Horie M, et al., HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013, Heart Rhythm, 2013;10:1932–63.

4. Bjerregaard P, Proposed diagnostic criteria for short QT syndrome are badly founded, J Am Coll Cardiol, 2011;58:549–50; author reply 550–41.

5. Gussak I, Brugada P, Brugada J, et al., Idiopathic short QT interval: a new clinical syndrome?, Cardiology, 2000;94:99–102.

6. Anttonen O, Junttila MJ, Maury P, et al., Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval, Heart Rhythm, 2009;6:267–71.

7. Anttonen O, Vaananen H, Junttila J, et al., Electrocardiographic transmural dispersion of repolarization in patients with inherited short QT syndrome, Ann Noninvasive Electrocardiol, 2008;13:295–300.

8. Maury P, Extramiana F, Giustetto C, et al., Microvolt T-wave alternans in short QT syndrome, Pacing Clin Electrophysiol, 2012;35:1413–9.

9. Lehmann MH, Suzuki F, Fromm BS, et al., T wave “humps” as a potential electrocardiographic marker of the long QT syndrome, J Am Coll Cardiol, 1994;24:746–54.

10. Sensoy B, Ozeke O, Canpolat U, et al., Postexercise recovery phase T-wave notching in concealed long QT syndrome, Herz, 2015;40:153–6.

11. Wedekind H, Schulze-Bahr E, Djonlagic H, Postextrasystolic “T wave hump” augmentation as a marker of increased arrhythmogenic risk in the long QT syndrome, Heart, 2002;88:633.

12. Anttonen O, Junttila J, Giustetto C, et al., T-Wave morphology in short QT syndrome, Ann Noninvasive Electrocardiol, 2009;14:262–7.

3

Article Information

Disclosure

Serhat Koca, Ozcan Ozeke, Serkan Cay, Firat Ozcan, Fazil Arisoy, Omer Alyan, Serkan Topaloglu and Dursun Arashave have no conflicts of interest to declare. No funding was received in the publication of this article.
Compliance with Ethics: All procedures were followed in accordance with the responsible committee on human experimentation and with the Helsinki Declaration of 1975 and subsequent revisions, and informed consent was received from the patient involved in this case study.
Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.

Correspondence

Ozcan Ozeke, Türkiye Yüksek Îhtisas Hastanesi, Kardiyoloji Klinigi, Ankara, 06100, Turkiye. E: ozcanozeke@gmail.com

Access

This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit.

Received

2017-02-11T00:00:00

4

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup